GREY:MDCGF - Post by User
Post by
SayitLykitizon Feb 23, 2011 6:51pm
258 Views
Post# 18183560
Quick recap on 2 articles posted today...
Quick recap on 2 articles posted today...Salient facts from the two articles posted earlier (dated Feb.22, 2011):
- 100 employees
- Two flagship products: H5N1 and H1N1 vaccines
- "By the end of 2011, we will count five new products in our pipeline, including three vaccines", lets slip CEO of the company Andy Sheldon. "Right now, that's all I can say. We do not want to alert our competitors".
- Currently $14.7M in coffers to carry out work
- Second stage of Phase 2 for H5N1 vaccine underway; results expected second quarter of 2011
- Seasonal flu vaccine Phase 1 study to commence second week of March (safety/tolerability of single dose, unadjuvanted vaccine)
- Intend to take first steps in the field of biosimilars (Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product - projected worldwide market of $125B by 2020)
Future looks bright. All you need to do now is forget you own it, and "remember" later on in 2012-13 :)